Navigation Links
Patients’ Immune System May Influence Immunotherapy
Date:4/2/2017

Higher or lower levels of certain immune cells in cancer patients may be associated with how well they respond to immunotherapy, according to preliminary results of a study conducted by researchers at the University of Pittsburgh Cancer Institute (UPCI).

The findings will be presented today at the American Association of Cancer Research (AACR) Annual Meeting in Washington, D.C., by Robert Ferris, M.D., Ph.D., UPMC Endowed Professor, chief of the Division of Head and Neck Surgery, and co-leader of the Cancer Immunology Program at UPCI.

The research was an extension of the recently completed CheckMate 141 Phase III clinical trial co-chaired by Dr. Ferris, which showed that the immunotherapy nivolumab significantly increases survival and causes fewer adverse side effects in patients with recurrent head and neck cancer.

However, the treatment was not equally effective in all the patients so Dr. Ferris and his team aimed to find out whether differences in the patients’ immune system profiles could be associated with better response to immunotherapy.

The researchers found that higher levels of tumor-associated immune cells (TAICs) expressing the PD-L1 protein were associated with longer overall survival and greater likelihood of response to the drug nivolumab. TAICs are immune cells that have infiltrated the tumor and are thought to play an important role in tumor growth.

In blood samples taken prior to the start of immunotherapy, the researchers also found that patients with higher levels of circulating CD8, or cytotoxic, T cells—also known as killer T cells—and lower levels of regulatory T cells were associated with better response to treatment.

“Our study shows that immune cells in the microenvironment around the tumor could play a critical role in how patients respond to immunotherapy. By determining the nature of these cells and how they are affected by treatments, we may be able to significantly improve the effectiveness of current therapies and help a greater number of patients,” said Dr. Ferris.

Additional U.S. institutions that participated in the CheckMate trial include Ohio State University, University of Texas MD Anderson Cancer Center, Stanford Cancer Institute, University of Chicago, Dana-Farber Cancer Institute and Bristol-Myers Squibb.

International collaborators are located at BC Cancer Agency in Canada; Centre Leon Berard, Centre Antoine Lacassagne, and Institut Gustave Roussy, all in France; Fondazione IRCCS Istituto Nazionale Tumori, and University of Milan in Italy; The Institute of Cancer Research, in the United Kingdom; University Hospital Essen, in Germany; Hospital Universitario 12 de Octubre, in Spain; University Hospital Zurich, in Switzerland; and National Cancer Center Hospital East in Japan.

This study was funded by UPCI and Bristol-Myers Squibb.

Read the full story at http://www.prweb.com/releases/2017/04/prweb14204710.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. Physicians ‘Like’ Patients’ Efforts to Self-Educate Online, Notes Dr. Shirin Towfigh
2. NY Breast Reconstruction Associates Honor Patients’ Journeys at The Uplifting Event
3. Get Real Health’s CHBase™ Gives Healthcare Providers a 360° View of Patients’ Health
4. Patients’ Healthcare Partners Celebrated During National Case Management Week
5. 449 Recovery Joins the MAP Recovery Network to Track Outcomes Data and Improve Patients’ Long-term Recovery Rates
6. Pulmonary Hypertension Association Part of Coalition Supporting the Patients’ Access to Treatments Act
7. North Shore-LIJ Completes Last Phase of $50M Upgrade of its Diagnostic Imaging Systems, $12M for GE Low-Dose CT Scanners to Reduce Patients’ Radiation Exposure
8. University of Colorado Cancer Center Study Shows How to Keep Nanoparticle Caterpillars Safe From the Crows of the Immune System
9. Introducing Zen Air Immune Boost Diffuser Blend of Essential Oils, Joining the Popular Topical Blend from Sublime Naturals for Wellness.
10. Advanced Cell Diagnostics Webinar on Surveying Expression of Immune Checkpoint Markers in Tissue Microenvironment
11. Chronic Inflammation of Obesity, Autoimmune Conditions Leads to Imbalanced Blood System and Potential Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/16/2018)... ... November 16, 2018 , ... Most of the ... reproductive system. However, changes in the color, smell, or consistency could be signs ... bothersome and result in a low self-esteem for many women. Although Over-the-Counter (OTC) ...
(Date:11/16/2018)... ... November 16, 2018 , ... The Colorado Rural Health Center (CRHC) ... and volunteers in our community during National Rural Health Day 2018. National Rural Health ... of those serving the health needs of over 60 million people across the nation. ...
(Date:11/16/2018)... ... November 16, 2018 , ... ... book Physician: How Science Transformed the Art of Medicine (GreenLeaf Press, 2018) was ... health and medical. , Interweaving moving personal patient stories with a historical ...
(Date:11/16/2018)... ... November 16, 2018 , ... Hangover Heaven®, ... intravenous medications and antioxidants, has changed its name to Hangover Heaven IV Hydration® ... always focused on IV therapy and IV hydration through our hangover cures products, ...
(Date:11/16/2018)... YORK (PRWEB) , ... November 16, 2018 , ... ... medical center, announced today a historic agreement with Taikang Healthcare in China to ... Taikang’s Xianlin Drum Tower Hospital in Nanjing, the capital of Jiangsu Province in ...
Breaking Medicine News(10 mins):
(Date:11/16/2018)... ... ... Florida Hospital, Championship Level Partner and Official Health and Wellness Partner of the ... Bolt Run, Saturday, November 17, 2018. The race consists of a 5 Mile, 5K, ... a few feet away from the ice! There are family-friendly activities all morning on ...
(Date:11/16/2018)... ... November 16, 2018 , ... Through its Microbiome Grant Initiative, ... design, planning, sample collection, and analysis to team of researchers at University of ... symptoms, infant cognitive/behavioral development, and the gut microbiome. , The goal of ...
(Date:11/16/2018)... ... November 16, 2018 , ... , ChiroTrust, Chiropractic’s first and ... care for their neck and back pain, is attracting patients back to Chiropractic. , ... time, if they need more patients, they have a bigger problem that more new ...
Breaking Medicine Technology: